These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6319866)

  • 1. Effect of inhalational anesthetics on the opioid receptors in the rat brain.
    Inoki R; Kim SY; Maeda S; Nakamae J; Mashimo T; Yoshiya I
    Life Sci; 1983; 33 Suppl 1():223-6. PubMed ID: 6319866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain.
    Ori C; Ford-Rice F; London ED
    Anesthesiology; 1989 Mar; 70(3):541-4. PubMed ID: 2564264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of opiate and other receptors in vitro by quasi-clinical concentrations of inhalational anesthetics.
    LaBella FS; Pinsky C; Lemon P
    Proc West Pharmacol Soc; 1988; 31():245-9. PubMed ID: 2850557
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of halothane and methoxyflurane on regional brain and spinal cord concentrations of methionine-enkephalin in the rat.
    Agarwal RK; Court M; Chandna VK; Mohan A; Engelking LR; Kumar AM
    Brain Res Bull; 1994; 35(3):273-7. PubMed ID: 7812809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord.
    Mack KJ; Killian A; Weyhenmeyer JA
    Life Sci; 1984 Jan; 34(3):281-5. PubMed ID: 6319937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of [3H](-)-SKF-10,047 with brain sigma receptors: characterization and autoradiographic visualization.
    Zukin SR; Tempel A; Gardner EL; Zukin RS
    J Neurochem; 1986 Apr; 46(4):1032-41. PubMed ID: 3005501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution.
    Maruyama M; Sugino H; Akita K; Hatanaka H
    Brain Res; 1987 Jan; 401(1):14-22. PubMed ID: 2880641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
    Su TP; Weissman AD; Yeh SY
    Life Sci; 1986 Jun; 38(24):2199-210. PubMed ID: 3012236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN; Das S
    Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.